Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.
Research output: Contribution to journal › Article
In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Publication status||Published - 2014|
No data available